Gamunex-C (GRIFOLS USA, LLC)
Welcome to the PulseAid listing for the Gamunex-C drug offered from GRIFOLS USA, LLC. This Human Immunoglobulin G [EPC],Passively Acquired Immunity [PE],Antigen Neutralization [MoA],Immunoglobulins [Chemical/Ingredient] pharmaceutical is classified as a PLASMA DERIVATIVE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same PLASMA DERIVATIVE drug type category.
| LABELER NAME / MANUFACTURER: | GRIFOLS USA, LLC |
| NON-PROPRIETARY NAME: | Immune Globulin (Human) |
| SUBSTANCE NAME: | HUMAN IMMUNOGLOBULIN G |
| TYPE: | PLASMA DERIVATIVE |
| PHARMA CLASS: | Human Immunoglobulin G [EPC],Passively Acquired Immunity [PE],Antigen Neutralization [MoA],Immunoglobulins [Chemical/Ingredient] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2010-10-13 |
| END MARKETING DATE: | 0000-00-00 |
Gamunex-C PLASMA DERIVATIVE Details:
| Item Description | Gamunex-C from GRIFOLS USA, LLC |
| LABELER NAME: | GRIFOLS USA, LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 10(g/100mL) |
| START MARKETING DATE: | 2010-10-13 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 13533-800_a396d2e6-bff1-4b9f-85b3-7e4c657f4465 |
| PRODUCT NDC: | 13533-800 |
| APPLICATION NUMBER: | BLA125046 |
Other HUMAN IMMUNOGLOBULIN G Pharmaceutical Manufacturers / Labelers:
